Ginsburg Drugs And Formulations Private Limited - Company Profile

It is a healthcare private limited company based in Gorakhpur, Uttar Pradesh, India, established in 2004.
2004 Gorakhpur, Uttar Pradesh, India Active
Last Updated:
Access Report
About Ginsburg Drugs And Formulations Private Limited

Ginsburg Drugs And Formulations Private Limited, a active private limited company, was established on 11 October 2004 in Gorakhpur, Uttar Pradesh, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U24232UP2004PTC029153. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

It upholds a compliant status. Its leadership includes Avnish Rao (Director), Vasu Vinayak Rao (Director), Shanti Bhushan Rao (Director). Past directors included Umesh Pratap Rao, Shri Narayan Rao, Kanti Devi Rao. It holds ₹5.10 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 229-Q Ground Floor Nh-28 Near Deoria By Pass Daudpur, Gorakhpur, Uttar Pradesh, 273016.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232UP2004PTC029153

  • Registration Number

    029153

  • Incorporation Date

    11 October 2004

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 21 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 5.10 M
  • Revenue Growth **** 9.90%
  • Profit Growth **** 3.59%
  • Ebitda **** -28.22%
  • Net Worth 6.55%
  • Total Assets **** 15.09%
Company report

Ginsburg Drugs And Formulations Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ginsburg Drugs And Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ginsburg Drugs And Formulations Private Limited?
Current Directors
Name Designation Appointment Date Status
Avnish Rao Director 19 Jan 2024 Current
Vasu Vinayak Rao Director 24 Feb 2024 Current
Shanti Bhushan Rao Director 11 Oct 2004 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 29 Feb 2024 Past
Pramod Abcsdd Director 04 Apr 2014 Past
Pramod Abcsdd Director 16 Jan 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ginsburg Drugs And Formulations.

Ginsburg Drugs And Formulations Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 9.9% increase. The company also saw a slight improvement in profitability, with a 3.59% increase in profit. The company's net worth moved up by a moderate rise of 6.55%.

Ginsburg Drugs And Formulations revenue growth over time
Ginsburg Drugs And Formulations profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 9.90%
*******
*******
*******
*******
Revenue from Operations
*******
 9.57%
*******
*******
*******
*******
Total Assets
*******
 15.09%
*******
*******
*******
*******
Profit or Loss
*******
 3.59%
*******
*******
*******
*******
Net Worth
*******
 6.55%
*******
*******
*******
*******
EBITDA
*******
 -28.22%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ginsburg Drugs And Formulations?

In 2017, Ginsburg Drugs And Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹5,095,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 0.36 Cr
  • Allahabd Bank : 0.15 Cr
Latest Charge Details
Date Lender Amount Status
03 Jul 2020 Others ₹3.60 M Open
28 Feb 2013 Allahabd Bank ₹1.50 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Ginsburg Drugs And Formulations?

Unlock and access historical data on people associated with Ginsburg Drugs And Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ginsburg Drugs And Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ginsburg Drugs And Formulations's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ginsburg Drugs And Formulations
Recent Activity within the Organization
  • Annual General Meeting

    The activity Ginsburg Drugs And Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Ginsburg Drugs And Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was documented.

  • Director Appointment

    Vasu Vinayak Rao was appointed as a Director was appointed as a Director on 24 Feb 2024 & has been associated with this company since 2 years 6 days . was recorded as a recent event.

  • Director Appointment

    The activity Avnish Rao was appointed as a Director was appointed as a Director on 19 Jan 2024 & has been associated with this company since 2 years 1 month . was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 3.60 M with Charge ID 100368631 was registered on 03 Jul 2020. was documented.

  • Charges

    A charge with Allahabd Bank amounted to Rs. 1.50 M with Charge ID 10413396 was registered on 28 Feb 2013. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ginsburg Drugs And Formulations Private Limited?

The CIN of Ginsburg Drugs And Formulations Private Limited is U24232UP2004PTC029153.

Where is Ginsburg Drugs And Formulations Private Limited headquartered?

Ginsburg Drugs And Formulations Private Limited is headquartered at 229-Q Ground Floor Nh-28 Near Deoria By Pass Daudpur, Gorakhpur, Uttar Pradesh, 273016.

When was Ginsburg Drugs And Formulations Private Limited incorporated?

Ginsburg Drugs And Formulations Private Limited was incorporated on 11 October 2004.

Who are the current directors of Ginsburg Drugs And Formulations Private Limited?

The current directors of Ginsburg Drugs And Formulations Private Limited are

What is the primary industry of Ginsburg Drugs And Formulations Private Limited?

The primary industry of Ginsburg Drugs And Formulations Private Limited is Trade.

Is Ginsburg Drugs And Formulations Private Limited a listed company?

Ginsburg Drugs And Formulations Private Limited is unlisted.

What is the capital structure of Ginsburg Drugs And Formulations Private Limited?

The authorized capital of Ginsburg Drugs And Formulations Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

What is the compliance status of Ginsburg Drugs And Formulations Private Limited?

The compliance status of Ginsburg Drugs And Formulations Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available